HIGHLIGHTS: Stable BPC-157, a novel anti-ulcer peptide (1) BPC-157: Healing in different tissues Tendon Healing (4) Bone healing BPC-157 & Neuroprotective effect Effect on Spinal Cord Injury Blood Pressure Tendon Healing (4) Bone healing Stable BPC-157 as anti-ulcer agent (1) Stable gastric pentadecapeptide BPC 157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis, lethal dose (dosage required to kill 1% of the test population, LD1) not reported
Traditional treatment through intramuscular injections has notable drawbacks, prompting the exploration of safer and more convenient methods such as intranasal administration
In stock Specifications Compound: BPC-157 Quantity: 10mg per vial Form: Lyophilised powder Purity: 98% (batch specific) Appearance: White to off-white powder Use: Laboratory research only Quality & Verification Each batch undergoes analytical testing to confirm identity and purity
Most evidence is preclinical, so patients should avoid treating these research themes as guaranteed clinical outcomes
When levels drop for long enough, nerve tissue can become irritated, slow, and vulnerable
see Cyanocobalamin injection for medical use details
